These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19339713)

  • 1. When to start antiretroviral therapy--ready when you are?
    Sax PE; Baden LR
    N Engl J Med; 2009 Apr; 360(18):1897-9. PubMed ID: 19339713
    [No Abstract]   [Full Text] [Related]  

  • 2. Timing of antiretroviral drugs during tuberculosis therapy.
    Kadhiravan T
    N Engl J Med; 2010 Jun; 362(22):2138; author reply 2138-9. PubMed ID: 20527060
    [No Abstract]   [Full Text] [Related]  

  • 3. Early versus deferred antiretroviral therapy for HIV.
    Gelinck LB; van der Ende ME
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701986
    [No Abstract]   [Full Text] [Related]  

  • 4. Early versus deferred antiretroviral therapy for HIV.
    Arribas JR; Mora M; Pascual-Pareja JF
    N Engl J Med; 2009 Aug; 361(8):823; author reply 823-4. PubMed ID: 19701985
    [No Abstract]   [Full Text] [Related]  

  • 5. Getting smarter--the toxicity of undertreated HIV infection.
    Currier JS; Baden LR
    N Engl J Med; 2006 Nov; 355(22):2359-61. PubMed ID: 17135590
    [No Abstract]   [Full Text] [Related]  

  • 6. Timing of antiretroviral drugs during tuberculosis therapy.
    Wilson D; Meintjes G
    N Engl J Med; 2010 Jun; 362(22):2137; author reply 2138-9. PubMed ID: 20519688
    [No Abstract]   [Full Text] [Related]  

  • 7. Should we be initiating antiretroviral therapy earlier? An argument in favour.
    Wood R
    S Afr Med J; 2005 Dec; 95(12):926, 928. PubMed ID: 16465350
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV therapy--what do we know, and when do we know it?
    Skolnik PR
    N Engl J Med; 2003 Dec; 349(24):2351-2. PubMed ID: 14668462
    [No Abstract]   [Full Text] [Related]  

  • 9. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression and fatal outcomes in HIV-infected patients during interruption of antiretroviral treatment.
    Cooper DA; Emery S; Cordery DV
    J Infect Dis; 2008 Mar; 197(5):775; author reply 775-6. PubMed ID: 18419355
    [No Abstract]   [Full Text] [Related]  

  • 11. Early versus deferred antiretroviral therapy for HIV.
    Hernán MA; Robins JM
    N Engl J Med; 2009 Aug; 361(8):822-3; author reply 823-4. PubMed ID: 19701984
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies of HIV management--when to start.
    Youle M
    AIDS; 2002; 16 Suppl 4():S145-9. PubMed ID: 12699011
    [No Abstract]   [Full Text] [Related]  

  • 13. Stopping antiretroviral therapy: role for therapeutic drug monitoring.
    Tommasi C; Nicastri E; Corpolongo A; Ivanovic J; Notari S; Ascenzi P; Andreoni M; Narciso P
    AIDS; 2008 Jan; 22(2):315-6. PubMed ID: 18097237
    [No Abstract]   [Full Text] [Related]  

  • 14. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy.
    O'Brien DP; Sauvageot D; Zachariah R; Humblet P;
    AIDS; 2006 Oct; 20(15):1955-60. PubMed ID: 16988517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of antiretroviral therapy in low-resource settings.
    Bendavid E
    Lancet; 2008 Jul; 372(9635):288-9; author reply 289. PubMed ID: 18657700
    [No Abstract]   [Full Text] [Related]  

  • 16. Rationing antiretroviral therapy in Africa--treating too few, too late.
    Ford N; Mills E; Calmy A
    N Engl J Med; 2009 Apr; 360(18):1808-10. PubMed ID: 19403900
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
    Shirasaka T
    Kekkaku; 2007 Nov; 82(11):845-8. PubMed ID: 18078110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline HIV RNA and the when to start question: time to stop asking this question?
    Mussini C
    AIDS; 2006 May; 20(8):1197-8. PubMed ID: 16691072
    [No Abstract]   [Full Text] [Related]  

  • 19. Early versus deferred antiretroviral therapy for HIV.
    Buchbinder SP; Jain V
    N Engl J Med; 2009 Aug; 361(8):822; author reply 823-4. PubMed ID: 19692695
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a practical method to assess antiretroviral adherence in HIV-infected Thai children.
    Plipat N; Kottapat U; Komoltri C; Voradilokkul J; Anansakunwatt W; Chearskul P; Lapphra K; Phongsamart W; Chearskul S; Chokephaibulkit K; Vanprapar N
    Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):828-34. PubMed ID: 18041298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.